SEC 13F Intelligence

Eventide Asset Management, LLC / COLL

Eventide Asset Management, LLC’s Collegium Pharmaceutical Inc Position

Does Eventide Asset Management, LLC own Collegium Pharmaceutical Inc (COLL)? Yes — 1.42M shares worth $47M (+0.78% of its 13F portfolio) as of Q1 2026, down from 1.88M shares the prior filed quarter.

Position Value
$47M
Q1 2026
Shares
1.42M
% of Portfolio
+0.78%
Quarters Held
30
currently held

Position History COLL

Reported value by quarter
Q4 ’18: $38MQ4 ’18Q1 ’19: $33MQ2 ’19: $32MQ3 ’19: $28MQ4 ’19: $50MQ4 ’19Q1 ’20: $40MQ2 ’20: $42MQ3 ’20: $51MQ4 ’20: $49MQ4 ’20Q1 ’21: $58MQ2 ’21: $62MQ3 ’21: $52MQ4 ’21: $49MQ4 ’21Q1 ’22: $54MQ2 ’22: $47MQ3 ’22: $42MQ4 ’22: $61MQ4 ’22Q1 ’23: $63MQ2 ’23: $57MQ3 ’23: $59MQ4 ’23: $81MQ4 ’23Q1 ’24: $102MQ2 ’24: $85MQ3 ’24: $102MQ4 ’24: $76MQ4 ’24Q1 ’25: $79MQ2 ’25: $78MQ3 ’25: $84MQ4 ’25: $87MQ4 ’25Q1 ’26: $47Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20261.42M$47M+0.78%
Q4 20251.88M$87M+1.36%
Q3 20252.39M$84M+1.38%
Q2 20252.64M$78M+1.37%
Q1 20252.64M$79M+1.57%
Q4 20242.64M$76M+1.38%
Q3 20242.64M$102M+1.76%
Q2 20242.63M$85M+1.45%
Q1 20242.63M$102M+1.60%
Q4 20232.63M$81M+1.32%
Q3 20232.63M$59M+1.06%
Q2 20232.63M$57M+0.96%
Q1 20232.63M$63M+1.16%
Q4 20222.63M$61M+1.20%
Q3 20222.63M$42M+0.83%
Q2 20222.63M$47M+1.00%
Q1 20222.63M$54M+0.84%
Q4 20212.63M$49M+0.63%
Q3 20212.63M$52M+0.68%
Q2 20212.63M$62M+0.84%
Q1 20212.43M$58M+0.85%
Q4 20202.43M$49M+0.75%
Q3 20202.43M$51M+0.99%
Q2 20202.43M$42M+0.92%
Q1 20202.43M$40M+1.28%
Q4 20192.43M$50M+1.41%
Q3 20192.43M$28M+0.92%
Q2 20192.43M$32M+0.97%
Q1 20192.21M$33M+1.15%
Q4 20182.21M$38M+1.68%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Eventide Asset Management, LLC’s full portfolio or all institutional holders of COLL.